Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Guidelines for glycemic control.

Stephen Clement1

  • 1Georgetown University, Washington, DC, USA.

Clinical Cornerstone
|January 5, 2005
PubMed
Summary
This summary is machine-generated.

This paper presents a treatment algorithm for diabetes management, offering guidance for healthcare providers. It aims to help achieve target blood glucose levels for all patients with diabetes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors.

BMJ open diabetes research & care·2023
Same author

Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices.

Alimentary pharmacology & therapeutics·2020
Same author

Medical Management of the Diabetic Patient.

Clinics in podiatric medicine and surgery·2019
Same author

Fungal thyroiditis in a lung transplant recipient.

BMJ case reports·2018
Same author

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States.

Clinical diabetes : a publication of the American Diabetes Association·2017
Same author

Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?

Liver international : official journal of the International Association for the Study of the Liver·2016
Same journal

Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options.

Clinical cornerstone·2009
Same journal

Guiding clinical decisions on abdominal obesity and cardiometabolic risk.

Clinical cornerstone·2009
Same journal

Overweight and obesity: the pathogenesis of cardiometabolic risk.

Clinical cornerstone·2009
Same journal

Obesity as a disease state: a new paradigm for diagnosis and treatment.

Clinical cornerstone·2009
Same journal

Pathogenesis of cardiometabolic risk as it relates to overweight and obesity. Introduction.

Clinical cornerstone·2009
Same journal

Should clinicians routinely determine rhinitis subtype on initial diagnosis and evaluation? A debate among experts.

Clinical cornerstone·2009
See all related articles

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Diabetes mellitus management is evolving with new medications and data.
  • The 2004 American Diabetes Association (ADA) guidelines introduced preprandial and postprandial glucose targets.
  • The ADA guidelines lack specific medication therapy recommendations.

Purpose of the Study:

  • To provide a detailed and easy-to-follow treatment algorithm for diabetes management.
  • To assist nurse practitioners and primary care providers in medication selection and therapy adjustments.
  • To support the goal of achieving euglycemia in all diabetes patients.

Main Methods:

  • Development of a practical treatment algorithm for diabetes care.
  • Integration of current understanding of diabetes pathophysiology and therapeutic agents.

Related Experiment Videos

  • Algorithm designed for usability by primary care providers and nurse practitioners.

    • Main Results:

    • A structured approach to diabetes medication management is proposed.
    • The algorithm facilitates adherence to updated glycemic targets.
    • It offers a framework for individualized patient care.

    Conclusions:

    • The proposed algorithm aids in implementing evidence-based diabetes treatment.
    • Continuous advancements in diabetes research will necessitate guideline updates.
    • The ultimate aim is to improve glycemic control and patient outcomes.